Merck, A9731-10G, Albumin human

Application
This recombinant variant is recommended for use in absorption, distribution, metabolism, and excretion (ADME) pharmacological research; cell culture; drug delivery research; and cryopreservation of cells.
Biochem/physiol Actions
Albumins are soluble monomeric proteins found in the body fluids and tissues of animals and in some plant seeds. Serum albumin functions as a carrier protein for steroids, fatty acids, and thyroid hormones. Serum albumins are also vital in regulating the colloidal osmotic pressures of blood.
Features and Benefits
Cellastim™ is a well defined, animal-free recombinant human albumin (rHA). Designed for cell culture applications, Cellastim is a powerful media supplement that outperforms plasma-derived human albumin, bovine serum albumin, and other sources of recombinant human albumin. Cellastim delivers consistent performance, not the variability associated with hydrolysates and extracts. Cellastim is ideally suited for use in cell culture media for Chinese Hamster Ovary (CHO), hybridoma, VERO, stem cells and primary cells.

Advantages
Eliminates animal-derived additives
Safe and regulatory friendly
Proven effective in enhancing stem cell growth in embryonic, mesenchymal, neural, cardiac, liver, kidney, keratinocyte and fibroblast stem cell lines
Maintains stem cells in an undifferentiated state
Eliminates coating of culture plates for adherent cell lines
Provides well-defined and consistent stem cell medium

Analysis Note
Assayed by SDS-PAGE
Other Notes
1). Patent Rights

EP2230311

U.S. Patent No. 10618951

U.S. Patent No. 10981974

U.S. Patent No. 11492389

2). Registered Trademark Rights

U.S. Reg. 5696531

International Reg. 1456207
To view more information on Cellastim download the Cellastim Brochure, Cellastim CHO Poster, and Cellastim hybridoma Poster.
View more information on human serum albumin.
Legal Information
rHSA manufactured in the USA by InVitria US Pat 10618951, 10981974, and 11492389.
Cellastim is a trademark of InVitria